EPI Program Achievements

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10AE06	TRESIBA	BioTech	Insulin degludec - 100IU/ml	100IU/ml	Injectable solution	6,857,628 L.L
A11DB	TRILAGAVIT	G	Vitamin B12 - 1mg/3ml, Vitamin B6 - 100mg/3ml, Vitamin B1 - 100mg/3ml		Injectable solution	579,196 L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1875mg/15ml	1875mg/15ml	Injectable solution	375,054,619 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
G02CX01	TRACTOCILE	B	Atosiban acetate - 7.5mg/ml	7.5mg/ml	Injectable solution	2,592,272 L.L
G02CX01	TRACTOCILE	B	Atosiban acetate - 7.5mg/ml	7.5mg/ml	Injectable solution	8,282,804 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml		Injectable solution	1,204,227,927 L.L
G03BA03	TESTOVIRON DEPOT	B	Testosterone Enantate - 250mg/ml	250mg/ml	Injectable solution	467,657 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	483,720,518 L.L
L01FX29	TALVEY	B	Talquetamab - 2mg/ml	3mg/1.5ml	Injectable solution	45,594,403 L.L
L01FX29	TALVEY	B	Talquetamab - 40mg/ml	40mg/ml	Injectable solution	555,916,745 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	2,027,858 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 8mg/4ml	8mg/4ml	Injectable solution	2,027,858 L.L
M01AB05	TRATUL	G	Diclofenac Deanol - 90mg	90mg	Injectable solution	490,503 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml		Injectable suspension	4,020,777 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	35,006,953 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	40,713,332 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,113,800 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	75,169,378 L.L
R02A	TRACHISAN	G	Lidocaine HCl - 1mg, Tyrothricin - 0.5mg, Chlorhexidine gluconate - 1mg		Lozenge	228,453 L.L
D11AH01	TACRUS	G	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	1,857,190 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
D11AX	TRIO-2000	G	Hydroquinone - 4%, Tretinoin - 0.05%, Hydrocortisone acetate - 1%		Ointment	2,495,068 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L

EPI Achievements